170889 ⎘
Detection or diagnosis of diseases; Pediatrics; Congenital anomalies Down syndrome; Trisomy 18; Trisomy 13
COMBINATIONS OF BIOMARKERS FOR METHODS FOR DETECTING TRISOMY 21
#2DETERMINING A NUCLEIC ACID SEQUENCE IMBALANCE ASSOCIATED WITH CANCER USING MULTIPLE MARKERS
#3PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING
#4DIAGNOSING FETAL CHROMOSOMAL ANEUPLOIDY USING MASSIVELY PARALLEL GENOMIC SEQUENCING
#5NONINVASIVE DIAGNOSIS OF FETAL ANEUPLOIDY BY SEQUENCING
#6DIAGNOSING FETAL CHROMOSOMAL ANEUPLOIDY USING MASSIVELY PARALLEL GENOMIC SEQUENCING
#7METHODS FOR EMBRYO SCREENING
#8NON-INVASIVE PRENATAL TESTING AT EARLY STAGE OF PREGNANCY
#9BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS
#10PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
#11Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing
#12Non-invasive prenatal testing at early stage of pregnancy
#13DOWN SYNDROME BIOMARKERS AND USES THEREOF
#14COMBINATIONS OF BIOMARKERS FOR METHODS FOR DETECTING TRISOMY 21
#15Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#16Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#17Compositions comprising cyclic peptides derived from an A-beta peptide
#18Noninvasive molecular controls
#19Noninvasive diagnosis of fetal aneuploidy by sequencing
#20Determining a nucleic acid sequence imbalance associated with cancer using multiple markers
#21Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
#22Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#23Determining a nucleic acid sequence imbalance using multiple markers
#24Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#25Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#26PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
#27METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#28Methods for screening for fetal trisomies
#29Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#30Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
#31Systems and methods for obtaining information associated with an anatomical sample using optical microscopy
#32EARLY PLACENTA INSULIN-LIKE PEPTIDE (PRO-EPIL)
#33GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#34Noninvasive diagnosis of fetal aneuploidy by sequencing
#35Anti-Aβ globulomer 4D10 antibodies
#36Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#37Blood-based screen for detecting neurological diseases in primary care settings
#38Uses of antibodies directed against amyloid-β
#39Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#40DEVICES AND METHODS FOR DETERMINING AND/OR ISOLATING CELLS SUCH AS CIRCULATING CANCER OR FETAL CELLS
#41METHOD OF IDENTIFYING FOETAL ERYTHROBLAST
#42PRENATAL SCREENING FOR DOWN SYNDROME AND TRISOMY 18
#43Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
#44Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
#45Noninvasive diagnosis of fetal aneuploidy by sequencing
#46Methods of detecting aneuploidy in human embryos
#47Noninvasive diagnosis of fetal aneuploidy by sequencing
#48Determining percentage of fetal DNA in maternal sample
#49Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
#50Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#51Methods and kits for detecting ITA in a biological sample
#52METHOD FOR QUANTIFYING THE EXTENT OF HUMAN-INTRODUCED VARIABILITY IN MEDICAL TEST DATA
#53Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
#54Biomarkers for the detection and screening of down syndrome
#55Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#56Noninvasive diagnosis of fetal aneuoploidy by sequencing
#57Adam12, A Novel Marker For Abnormal Cell Function
#58Protofibril selective antibodies and the use thereof
#59Methods for the diagnosis of fetal disease
#60Diagnostic antibody assay
#61DIAGNOSTIC AND THERAPEUTIC TREATMENTS RELATED TO MITOCHONDRIAL DISORDERS
#62Noninvasive Diagnosis of Fetal Aneuploidy by Sequencing
#63Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#64Noninvasive diagnosis of fetal aneuploidy by sequencing
#65Methods and apparatus for screening for chromosomal abnormalities
#66Methods and kits for detecting ITA in a biological sample
#67METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE
#68METHODS AND COMPOSITIONS FOR CELL STABILIZATION
#69USE OF A CAMELID SINGLE-DOMAIN ANTIBODY FOR DETECTING AN OLIGOMERIC FORM OF AN AMYLOID BETA PEPTIDE AND ITS APPLICATIONS
#70Methods for Predicting Trisomy 21 in a Fetus
#71ADAM12, a novel marker for abnormal cell function
#72Noninvasive diagnosis of fetal aneuploidy by sequencing
#73METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#74Noninvasive Diagnosis of Fetal Aneuploidy by Sequencing
#75GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#76Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
#77Upregulation of Adamts4 Protease Activity for the Treatment of Alzheimer's Disease
#78Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
#79Protofibril selective antibodies and the use thereof
#80Anti-Aβ globulomer 5F7 antibodies
#81Marker for Chromosomal Abnormalities
#82Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#83Methods and kits for detecting ITA in a biological sample
#84Determining a nucleic acid sequence imbalance
#85Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
#86Rage Fusion Proteins And Methods Of Use
#87Non-invasive prenatal genetic diagnosis using transcervical cells
#88Treatment of Chromosomal Abnormalities in Fetuses Through A Comprehensive Metabolic Analysis of Amniotic Fluid
#89Diagnostic and Therapeutic Treatments Related to Mitochondrial Disorders
#90Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
#91Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
#92Methods and apparatus for screening for chromosomal abmormalities
#93Neuroprotective activity of activated protein c independent of its anticoagulant activity
#94Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
#95ADAM12, a novel marker for abnormal cell function
#96Diagnosis of fetal aneuploidy
#97Non-invasive prenatal genetic diagnosis using transcervical cells
#98Non-invasive prenatal genetic diagnosis using transcervical cells
#99Multi-marker screening protocol for fetal abnormalities
#100Non-invasive prenatal genetic diagnosis using transcervical cells